New technology has enabled doctors to administer higher doses of radiation to prostate cancer patients with fewer side effects. However, a new study shows that escalating the dose may not actually help a patient in the long term, at least not patients with localized prostate cancer. Read the article.
For prostate cancer, more radiation may not improve survival Read More »
Technology developed in Oxford to make tumour cells fluorescent could improve surgery outcomes for men with prostate cancer. Fluorescent compounds show up diseased cells during keyhole operations, allowing surgeons to be more precise when removing the prostate and tissue around it. Read the article.
Pioneering Oxford surgery technique could improve treatment for prostate cancer Read More »
Keep your pecker up, Bill…new prostate cancer zapper won’t wreck your love life! Pioneering soundwave treatment proves as effective as surgery. • High-intensity focused ultrasound blasts tumours with soundwaves • Study shows its 93 per cent success rate as effective as surgery • But rate of erectile dysfunction in HIFU patients post treatment much lower • ‘Experimental’ treatment not widely available in UK and costs £10,000 Read the article.
Calgary Tom Baker Cancer Centre radiation oncologist Dr. Siraj Husain discusses advances and new studies in the growing area of Salvage Brachytherapy. He starts with a quick but informative overview of prostate cancer, its diagnosis and treatments, and then launches into studies with graphic slides that show the groundbreaking work that is being done today in the field. Very informative, and the future looks very bright in the field of prostate cancer treatment. A lively discussion follows, including talk about the whole PSA debate. Watch the video.
New advances in salvage brachytherapy Read More »
A panel of experts at the American Society of Clinical Oncology (ASCO) have reviewed and endorsed Cancer Care Ontario’s guideline on Active Surveillance for the Management of Localized Prostate Cancer. The guidelines, published in May 2015, “are clear, thorough, and based upon the most relevant scientific evidence,” wrote Ronald C. Chen, MD, MPH, associate professor in the department of radiation oncology at UNC-Chapel Hill, and coauthors. Read the article.
ASCO Endorses Localized Prostate Cancer Guideline Read More »
Researchers have found a possible association between radiotherapy for the treatment of prostate cancer and an increased risk of developing secondary cancers of the bladder, colorectal tract, and rectum. Read the article.
Significant cost variations existed between competing treatments for low-risk prostate cancer from the time of diagnosis through treatment, according to the results of a time-driven activity-based costing analysis. Read the article.
Costs of competing treatments for low-risk prostate cancer vary widely Read More »
Two papers from University College London show that having early chemotherapy improves survival for men with prostate cancer. Read the article.
Early chemotherapy improves survival for men with prostate cancer Read More »
A survey showed men who underwent radical prostatectomy, especially robotic radical prostatectomy, had unrealistic expectations about how well they would function sexually postoperatively. Read the article.
Men Unclear on Sexual Function After Prostatectomy Read More »
The results of a study support an association between the use of androgen deprivation therapy (ADT) in the treatment of prostate cancer and an increased risk of Alzheimer’s disease in a general population cohort. Read the article.
Common prostate cancer treatment may double Alzheimer’s risk Read More »